University of Cambridge > Talks.cam > SciBar Cambridge > Engineering Immunity: T cell-driven immunotherapy and the future of medicine

Engineering Immunity: T cell-driven immunotherapy and the future of medicine

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Vasee.

Michael Harris, PhD student at the Department of Medicine, will talk about his study on T cell activation. T cells are key effectors and regulators of the immune response to infections and cancer. Recent decades have seen our understanding of the molecular mechanisms of T cell activation advance significantly. This knowledge is being used to engineer patient-specific immunotherapies and circumvent cancer’s immune-evasions mechanisms.

This talk is part of the SciBar Cambridge series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

© 2006-2019 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity